Concord Drugs Ltd Performance
Day's Low
Day's High
₹35.8₹37.7952 Week's Low
52 Week's High
₹30.59₹61.5
| Returns % | |
| 1 Month Return | + 1.73 % |
| 3 Month Return | -2.2 % |
| 1 Year Return | + 3.21 % |
| Market Stats | |
| Previous Close | ₹35.74 |
| Open | ₹36.00 |
| Volume | 24.10K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹35.74Cr |
Concord Drugs Ltd Key Statistics
| P/E Ratio | -70.53 |
| PEG Ratio | 30.27 |
| Market Cap | ₹35.74 Cr |
| P/B Ratio | 1.04 |
| EPS | 0.47 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 1.28 |
Concord Drugs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹35.74 Cr | 17.86% | 0.67 | ₹1 Cr | ₹44 Cr | |
| NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
| NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
| NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
About Concord Drugs Ltd
Share Price: ₹35.97 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹35.74Cr as of today
Revenue: ₹12.36Cr as on September 2024 (Q3 24)
Net Profit: ₹0.04Cr as on September 2024 (Q3 24)
Chairperson Name: S Nagi Reddy
| Organisation | Concord Drugs Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Insights on Concord Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 11.69 Cr → 12.37 Cr (in ₹), with an average increase of 5.5% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 44.59% to 45.61% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -0.34 Cr → 0.04 Cr (in ₹), with an average increase of 629.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 108.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 59.4%
NEGATIVE IMPACTPrice Dip
In the last 6 months, Concord Drugs stock has moved down by -10.7%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 55.41% to 54.39% in Sep 2024 quarter
Concord Drugs Ltd Financials
Concord Drugs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.39% | ||
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.61% | 2.27 | |
| Others | 0% | 0.00 |
Concord Drugs Ltd Key Indicators
Concord Drugs Ltd Valuation
Concord Drugs Ltd in the last 5 years
Lowest (-75.65x)
November 7, 2024
Today (-70.53x)
November 22, 2024
Industry (54.77x)
November 22, 2024
Highest (791.40x)
July 3, 2024
Concord Drugs Ltd Earnings and Dividends
Concord Drugs Ltd Earnings Results
Concord Drugs Ltd’s net profit fell -92.86% since last year same period to ₹0.04Cr in the Q2 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 33.33% jump in its net profits since last 3-months.
Read More about Earnings Results
Concord Drugs Ltd Technicals Summary
Bearish
Neutral
Bullish
Concord Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Concord Drugs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Concord Drugs Ltd shares.
Concord Drugs Ltd (538965) share price today is ₹35.97
Concord Drugs Ltd is not listed on NSE
Concord Drugs Ltd is listed on BSE
- Today’s highest price of Concord Drugs Ltd is ₹37.79.
- Today’s lowest price of Concord Drugs Ltd is ₹35.8.
PE Ratio of Concord Drugs Ltd is -70.53
PE ratio = Concord Drugs Ltd Market price per share / Concord Drugs Ltd Earnings per share
Today’s traded volume of Concord Drugs Ltd(538965) is 24.10K.
Today’s market capitalisation of Concord Drugs Ltd(538965) is ₹35.74Cr.
| Concord Drugs Ltd(538965 | Price |
|---|---|
52 Week High | ₹61.5 |
52 Week Low | ₹30.59 |
Concord Drugs Ltd(538965) share price is ₹35.97. It is down -41.51% from its 52 Week High price of ₹61.5
Concord Drugs Ltd(538965) share price is ₹35.97. It is up 17.59% from its 52 Week Low price of ₹30.59
| Concord Drugs Ltd(538965 | Returns |
|---|---|
1 Day Returns | 0.23% |
1 Month Returns | 1.73% |
3 Month Returns | -2.2% |
1 Year Returns | 3.21% |